|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00952549 |
|
Date of registration:
|
04/08/2009 |
|
Primary sponsor: |
|
|
Public title:
|
Facial Yoga Toning Program - A Pilot Study
|
|
Scientific title:
|
Facial Yoga Toning Program - A Pilot Study |
|
Date of first enrolment:
|
August 2009 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT00952549 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Rebecca Tung, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
The Cleveland Clinic |
|
|
Name:
|
Wilma Bergfeld, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
The Cleveland Clinic |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- over age 18 years
Exclusion Criteria:
- pregnancy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Facial Atrophy Related to Age
|
|
Intervention(s)
|
|
Procedure: Facial Yoga Toning Program
|
|
Primary Outcome(s)
|
|
Clinical evaluations will be performed at each follow-up visit: 2 weeks, 4 weeks, 6 weeks and 8 weeks. Level of improvement will be quantified using the Global Aesthetic Improvement Scale.
[Time Frame: 8 weeks]
|
|
Secondary Outcome(s)
|
|
Secondary measures at each visit will also include level of subject satisfaction with the program and subject's assessment of any improvement in their overall appearance (based on the scale above).
[Time Frame: 8 weeks]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|